Crowd behavior classification based on generic descriptors by Wong, Pei Voon, Mustapha, Norwati, Affendey, Lilly Suriani, Khalid, Fatimah, Chen, Yen Lin

Get full text

Perforated acute appendicitis resulting from appendiceal villous adenoma presenting with small bowel obstruction: a case report by Cheng Yi-Chiao, Chen Yen-Lin, Chang Hao-Ming, Chen Yu-Guang, Hsu Chin-Hui

Get full text

Ixekizumab treatment patterns and healthcare utilization and costs for patients with psoriasis by Mwangi J. Murage, Adrienne M. Gilligan, Oth Tran, Orin Goldblum, Russel Burge, Chen-Yen Lin, Abrar Qureshi

Get full text

Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension by Alexandra B. Kimball, Thomas Luger, Alice Gottlieb, Luis Puig, Roland Kaufmann, Russel Burge, Chen-Yen Lin, Gil Yosipovitch

Get full text

Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST by Maxime Dougados, Atul Deodhar, Jürgen Braun, Uta Kiltz, Chen-Yen Lin, Tetsuya Tomita, Rebecca Bolce, Jessica Walsh, David Sandoval

Get full text

Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis by Elizabeth D. Bacci, Amy M. DeLozier, Chen-Yen Lin, Carol L. Gaich, Terence Rooney, Richard Hoffman, Kathleen W. Wyrwich

Get full text

Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient’s perspective by Neil J. Korman, William Malatestinic, Orin M. Goldblum, Mwangi J. Murage, Lisa Renda, Chen-Yen Lin, James Lucas, Chloe Middleton, Steven Lobosco

Get full text

Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies by Bernard Combe, Tsen-Fang Tsai, J. Eugene Huffstutter, Aubrey Trevelin Sprabery, Chen-Yen Lin, So Young Park, Andris Kronbergs, Matthew M. Hufford, Peter Nash

Get full text

Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis by Elizabeth D. Bacci, Amy M. DeLozier, Chen-Yen Lin, Carol L. Gaich, Xiang Zhang, Terence Rooney, Stephanie de Bono, Richard Hoffman, Kathleen W. Wyrwich

Get full text

Disease response and patient-reported outcomes among initiators of ixekizumab by Mona Shahriari, Ryan W. Harrison, Russel Burge, Chen-Yen Lin, William N. Malatestinic, Orin M. Goldblum, Robert R. McLean, Margaux M. Crabtree, Jacqueline O’Brien, Elsie L. Grace, Mwangi J. Murage

Get full text

Deciphering the evolution of composite-type GSKIP in mitochondria and Wnt signaling pathways. by Cheng-Yu Tsai, Shean-Jaw Chiou, Huey-Jiun Ko, Yu-Fan Cheng, Sin-Yi Lin, Yun-Ling Lai, Chen-Yen Lin, Chihuei Wang, Jiin-Tsuey Cheng, Hsin-Fu Liu, Aij-Li Kwan, Joon-Khim Loh, Yi-Ren Hong

Get full text

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials by Craig Leonardi, Kristian Reich, Peter Foley, Hideshi Torii, Sascha Gerdes, Lyn Guenther, Melinda Gooderham, Laura K. Ferris, Christopher E. M. Griffiths, Hany ElMaraghy, Heidi Crane, Himanshu Patel, Russel Burge, Gaia Gallo, David Shrom, Ann Leung, Chen-Yen Lin, Kim Papp

Get full text